Metropolitan Life Insurance Company (MetLife)’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-14,143
| Closed | -$846K | – | 2605 |
|
|
2019
Q4 | $846K | Sell |
14,143
-310
| -2% | -$18.6K | 0.01% | 993 |
|
|
2019
Q3 | $406K | Buy |
14,453
+1,603
| +12% | +$45K | 0.01% | 1422 |
|
|
2019
Q2 | $487K | Buy |
12,850
+294
| +2% | +$11.1K | 0.01% | 1324 |
|
|
2019
Q1 | $490K | Hold |
12,556
| – | – | 0.01% | 1313 |
|
|
2018
Q4 | $268K | Buy |
12,556
+1,971
| +19% | +$42K | 0.01% | 1616 |
|
|
2018
Q3 | $419K | Hold |
10,585
| – | – | 0.01% | 1493 |
|
|
2018
Q2 | $404K | Buy |
10,585
+4,877
| +85% | +$186K | 0.01% | 1463 |
|
|
2018
Q1 | $172K | Hold |
5,708
| – | – | ﹤0.01% | 1989 |
|
|
2017
Q4 | $178K | Sell |
5,708
-5,791
| -50% | -$181K | ﹤0.01% | 1982 |
|
|
2017
Q3 | $322K | Hold |
11,499
| – | – | ﹤0.01% | 1992 |
|
|
2017
Q2 | $220K | Buy |
+11,499
| New | +$220K | ﹤0.01% | 2281 |
|